The Food and Drug Administration has reinstated dozens of specialized employees involved in food safety, the review of medical appliances and other sectors last week, according to more than twelve workers back.
The total number of employees revoked was not immediately clear. But a person who was familiar with the conversations said that almost all the about 180 medical employees who had left to get their jobs back. More than twelve employees in a handful of groups said they had received a call or e -mail restoring their employment. Some reported that until twelve others in their teams they had also returned.
The FDA and his parental service, the Ministry of Health and Human Services, did not respond to comments.
Employees had been fired in the context of Trump’s efforts, led by Elon Musk, to significantly reduce the federal government and reduce costs. However, the salaries of many FDA staff members funded by the FDA funded were funded by the pay companies paying the FDA, not taxpayers’ money.
Many of the jobs were funded by such fees, but some employees were still out of work. Those whose job was funded by a special tax on cigarettes, for example, said they were not invited to work to work on the weekend. These workers examined applications for new tobacco products and studied the safety of emerging tobacco products, including electronic cigarettes and devices that heat tobacco but do not burn it.
On Friday, the New York Times presented the accounts of staff members who revised the safety of surgical robots, cardiovascular devices and diabetes systems involving insulin. Everyone had their job behind Monday morning.
Advamed, a trade union for medical manufacturers, had pushed the administration into a letter and meetings to ensure that workers who revised these products took back their jobs. Industry funds helped experts renting the device division, including doctors with experience using the devices. Industry funds are periodically approved in agreements voted by Congress, which also include strict deadlines for approval decisions.
Repetitive workers, who spoke about the condition of anonymity because they were afraid of retaliation, said that twelve executives from the agency’s chief adviser took back their jobs, including lawyers who supported the policy of medication. About twelve overseas cardiovascular devices and another 12 that also allow artificial intelligence programs. Others were called back to their jobs by evaluating food-chemical safety safety, the priority of the new Health Secretary, Robert F. Kennedy Jr.
In interviews, employees who returned on Monday reported a sense of whiplash and frustration and relief to return to work.
Dr. Robert Califf, Commissioner of the FDA during Biden’s administration, called on staff to reduce “anti-performance” because many recent recruitment had been hired to fill the gaps of knowledge in the organization, including artificial intelligence and intelligence Chemical security. He also said that the cuts were made without taking into account the well -being of workers.
“It is depressing to deal with fellow people in this way and a sign of immaturity of the people who do it,” he said in a text message on Monday.
Employees who had been evenly fired had been said that their performance was insufficient to justify further employment by the organization. “However, many of the redundant workers – restored and not – said that the organization’s performance reviews were excellent.
Alice Callahan They contributed reports.
